Literature DB >> 61340

Is the adrenergic control of renin release dominant in man?

R Davies, J D Slater.   

Abstract

Two beta-blocking agents with different properties were used to define the adrenergic component of the renin release which follows orthostasis. Five normal young subjects were tilted to 85 degrees for 30 min on four separate occasions. In two control studies the release of renin, as indicated by changes in plasma-renin activity, was highly reproducible. The effects of intravenous oxprenolol and intravenous propranolol, were then compared under the same experimental conditions. Oxprenolol attenuated the renin response in all subjects without completely abolishing it. Propranolol completely abolished the renin response. The difference in the ability of these agents to suppress renin release may be related to the presence (oxprenolol) or absence (propranolol) of intrinsic sympathomimetic activity. The increased rate of renin release in orthostasis seems to be mediated entirely by the adrenergic nervous system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61340     DOI: 10.1016/s0140-6736(76)90665-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  The interrelationship between the release of renin and vasopressin as defined by orthostasis and propranolol.

Authors:  R Davies; M L Forsling; J D Slater
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

2.  Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.

Authors:  I B Davies; P S Sever; T Rosenthal
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

3.  Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.

Authors:  S Sonkodi; E Agabiti-Rosei; R Fraser; B J Leckie; J J Morton; A M Cumming; V P Sood; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

4.  The inhibiton of adrenergically provoked renin release by salbutamol in man.

Authors:  R Wiggins; R Davies; I Basar; J D Slater
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

5.  Bopindolol: a new long acting beta-receptor antagonist; its effects on haemodynamics, and on the renin response to tilting.

Authors:  D R Turner; F J Goodwin; A R Knight; D W Littlejohns; V L Sharman; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

6.  A pathophysiologic study of the hypertension associated with burn injury in children.

Authors:  M B Popp; E B Silberstein; L S Srivastava; J M Loggie; H C Knowles; B G MacMillan
Journal:  Ann Surg       Date:  1981-06       Impact factor: 12.969

7.  Insulin-induced hypoglycaemia increases plasma concentrations of angiotensin II and does not modify atrial natriuretic polypeptide secretion in man.

Authors:  M Trovati; P Massucco; E Mularoni; F Cavalot; G Anfossi; L Mattiello; G Emanuelli
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

8.  Effect of beta-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects.

Authors:  R Vandongen; L Davidson; L J Beilin; A E Barden
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.